Lung Health Institute Presents New Findings at 7th Annual International Symposium on Regenerative Rehabilitation

TAMPA, Fla., Oct. 18, 2018 /PRNewswire/ -- Lung Health Institute's experienced physicians presented compelling findings at the 7th Annual International Symposium on Regenerative Rehabilitation. Jack Coleman Jr., M.D., FACS and Melissa Rubio, Ph.D., APRN addressed the need for new, comprehensive approaches to treating Chronic Obstructive Pulmonary Disease (COPD) at the world's largest medical and scientific conference specific to regenerative rehabilitation.

The abstract, "Combining Traditional Medicine, Regenerative Treatment and Current Technology to Optimize Care of Patients with Chronic Obstructive Pulmonary Disease (COPD)," shows the potential for  the effectiveness of combining multiple methods of treatment: conventional therapy, regenerative therapy and pulmonary rehabilitation through the Lift Pulmonary Rehab© program, an online, low cost, home-based pulmonary rehabilitation program available via smartphone, tablet or computer. The exciting findings from this research include:

• Regenerative treatment is shown to be effective in improving the severity of lung obstruction and quality of life in patients: In fact, in a retrospective study of 400 patients that underwent the autologous cellular therapy, 56% had an improvement in their Forced Expiratory Volume in 1 second (FEV1). FEV1 is a direct reflection of the severity of obstruction and is the standard for determining a patient's COPD GOLD (Global Initiative for Chronic Obstructive Lung Disease) Stage. Additionally, results of a patient-reported questionnaire showed that 77% of patients reported improved quality of life after 3 months.
      
• Guided pulmonary rehabilitation using technology is a successful method of engaging patients with COPD: In two prospective studies of patients participating in the online program of daily classes of physical activity, there was a 142% improvement in exercise capacity. There was also a 37% improvement in quality of life reported.

COPD is a prevalent issue in the United States and beyond. As many as 210 million patients currently are diagnosed with the disease across the globe, and according to the World Health Organization (WHO), it will be the third leading cause of death worldwide by 2020. This fact, combined with the results from Dr. Coleman and Dr. Rubio's studies, supports the need for an integrated approach that combines traditional medicine, regenerative treatment and current communications technology for the overall treatment of COPD.

To learn more about how Lung Health Institute is working to advance COPD treatment, visit thelunghealthinstitute.com.

About Lung Health Institute

Lung Health Institute leads the industry in regenerative medicine and is among the first cellular therapy providers accredited by The Joint Commission, widely considered the gold standard of quality patient care. Our exclusive focus on and multidisciplinary approach to lung disease yields expert care for every patient, even when conventional treatment isn't effective or stops working. Offering a variety of programs and services including the Anti-Inflammatory Initiativetm and cellular therapy in several locations across the United States, Lung Health Institute has helped thousands of people with chronic lung disease improve their quality of life and Breathe Easiertm. For more information, visit thelunghealthinstitute.com.

SOURCE Lung Health Institute